Icon Plc (ICLR) Stock Price, Quote & News

Company Profile

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and p...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 353 1 291 2000

Fax: 353 1 247 6260

Website: www.iconplc.com

Address:

South County Business Park, Leopardstown, Dublin, Ireland

ZacksResearch Jun. 2 at 4:17 PM

Why I’m holding $ICLR — and not letting go right now 👇 ICON is gaining traction with strong investor optimism tied to its AI-driven clinical delivery push and standout strategic partnerships. See why the long-term setup still looks strong 👉 https://www.zacks.com/stock/news/2480401/heres-why-you-should-retain-iclr-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2480401-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2480401_TEASER

1 · Reply

ZacksResearch Jun. 2 at 2:50 PM

$ICLR down 37.9% YTD — is the sell-off overdone? Despite macro pressures and currency woes, ICON is leveraging AI and strategic partnerships to optimize clinical delivery. The company even introduced new AI tools like iSubmit and SmartDraft in Q1 to streamline operations. Find out if ICON can turn things around here 👉 https://www.zacks.com/commentary/2480401/heres-why-you-should-retain-iclr-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2480401-body&ADID=SYND_STOCKTWITS_TWEET_2_2480401_BODY

0 · Reply

poissonpilled May. 30 at 1:33 AM

$ICLR not a bad setup

0 · Reply

Vivific May. 28 at 6:32 AM

$ICLR The vast majority of clinical trials are not affected by the funding cuts and policy changes. Trump's canceling of some federal funding for some trials was April news and the decline in ICLR stock price has caused an over-sold condition.

0 · Reply

Vivific May. 27 at 7:35 PM

$ICLR Volume finally above average on an up day! Shorts will be buying back a lot of shares soon!

0 · Reply

Vivific May. 27 at 7:25 PM

$ICLR May 13th, LockStocknProfit wrote, "Short" and clicked "Bearish". A week later he posts a lie to manipulate the stock downward, saying all clinical trials in the US are cancelled, etc. This sounds illegal. This company is rock solid!

0 · Reply

LockStocknProfit May. 21 at 2:53 AM

$ICLR all clinical trials in the US are canceled. Pharma is dead. No new medicines will ever be developed. ICLR is no longer needed.. going to 0.

4 · Reply

clowngenius May. 20 at 4:02 PM

$ICLR i want to wait a little more for some flush but right here would also make sense for a starter. also, when long term trendline is taken out, they light to overshoot it quite a bit only to have it retest that on the bounce. that would make for some good return. watching it, thanks.

0 · Reply

JarvisFlow May. 15 at 3:15 PM

Mizuho has updated their rating for Icon ( $ICLR ) to Outperform with a price target of 173.

0 · Reply

CautiousInvestor538 May. 13 at 11:21 PM

$ICLR short

0 · Reply

ICON plc Schedules Second Quarter 2025 Earnings Conference Call

Jun 2, 2025, 4:12 AM EDT - 21 days ago

ICLR Shareholders Have the Right to Lead the ICON Public Limited Company Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ICLR

May 27, 2025, 8:30 AM EDT - 27 days ago

ICON plc to Present at the William Blair 45th Annual Growth Stock Conference

May 19, 2025, 4:15 PM EDT - 4 weeks ago

ICON releases its ICON Cares 2024 Report

May 7, 2025, 7:27 AM EDT - 6 weeks ago

Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies

May 2, 2025, 2:42 AM EDT - 7 weeks ago

ICON Public Limited Company (ICLR) Q1 2025 Earnings Call Transcript

Apr 30, 2025, 4:15 PM EDT - 7 weeks ago

ICON Reports First Quarter 2025 Results

Apr 10, 2025, 8:55 AM EDT - 2 months ago

GreensKeeper Q1 2025 Portfolio Update

AXP CHKP ELV GOOG GOOGL ICE VRTX

Apr 4, 2025, 3:45 AM EDT - 2 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ICON

Mar 31, 2025, 6:30 AM EDT - 3 months ago

ICON plc Schedules First Quarter 2025 Earnings Conference Call

Mar 24, 2025, 5:09 PM EDT - 3 months ago

BetterInvesting™ Magazine Update on Lowe's Cos. (NYSE: LOW) and ICON PLC (NASDAQ: ICLR)

LOW

Mar 20, 2025, 4:00 AM EDT - 3 months ago

ICON Becomes the First Large Clinical Research Organization to Fully Integrate Medidata Clinical Data Studio, Streamlining Data Management and Review

Mar 17, 2025, 5:45 AM EDT - 3 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 11, 2025 in ICON Lawsuit - ICLR

Mar 6, 2025, 5:45 AM EST - 3 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 11, 2025 in ICON Public Limited Company Lawsuit - ICLR

Mar 5, 2025, 7:30 AM EST - 3 months ago

ICON plc to Present at Upcoming Investor Conferences

Mar 2, 2025, 7:28 AM EST - 4 months ago

ICLR REMINDER: ICON plc was Sued for Securities Fraud; Investors are Alerted to Contact BFA Law before April 11 Deadline (NASDAQ:ICLR)

Feb 27, 2025, 5:45 AM EST - 4 months ago

Shareholders of ICON Public Limited Company Should Contact The Gross Law Firm Before April 11, 2025 to Discuss Your Rights - ICLR

Feb 26, 2025, 8:56 PM EST - 4 months ago

Robbins LLP Reminds ICON PLC (ICLR) Investors With Large Losses to Contact the Firm to Learn How They Can Recover for Their Losses

Feb 24, 2025, 6:30 PM EST - 4 months ago

Kessler Topaz Meltzer & Check, LLP Encourages ICON Public Limited Company Investors with Losses to Contact the Firm

Feb 24, 2025, 1:27 PM EST - 4 months ago

ICON: An Excellent Investment Opportunity With Strong Growth Potential

Feb 21, 2025, 3:17 PM EST - 4 months ago

ICLR SECURITIES NEWS: ICON plc has been Sued for Securities Fraud - Investors are Alerted to Contact BFA Law by April 11 Legal Deadline (NASDAQ:ICLR)

Feb 20, 2025, 5:28 PM EST - 4 months ago

ICLR Investors are Suing ICON PLC; Contact Robbins LLP for More Information

Feb 20, 2025, 2:48 PM EST - 4 months ago

ICON Public Limited Company (ICLR) Q4 2024 Earnings Conference Call Transcript

Feb 19, 2025, 9:16 PM EST - 4 months ago

ICLR REMINDER: Kessler Topaz Meltzer & Check, LLP Urges ICLR Investors with Losses to Contact the Firm

Feb 19, 2025, 4:15 PM EST - 4 months ago

ICON Reports Fourth Quarter and Full Year 2024 Results

Feb 16, 2025, 7:13 AM EST - 4 months ago

ICLR COURT NEWS: ICON plc has been Sued for Securities Fraud; Contact BFA Law by April 11 if You Lost Money (NASDAQ:ICLR)

ZacksResearch Jun. 2 at 4:17 PM

1 · Reply

ZacksResearch Jun. 2 at 2:50 PM

0 · Reply

poissonpilled May. 30 at 1:33 AM

$ICLR not a bad setup

0 · Reply

Vivific May. 28 at 6:32 AM

0 · Reply

Vivific May. 27 at 7:35 PM

$ICLR Volume finally above average on an up day! Shorts will be buying back a lot of shares soon!

0 · Reply

Vivific May. 27 at 7:25 PM

0 · Reply

LockStocknProfit May. 21 at 2:53 AM

$ICLR all clinical trials in the US are canceled. Pharma is dead. No new medicines will ever be developed. ICLR is no longer needed.. going to 0.

4 · Reply

clowngenius May. 20 at 4:02 PM

0 · Reply

JarvisFlow May. 15 at 3:15 PM

Mizuho has updated their rating for Icon ( $ICLR ) to Outperform with a price target of 173.

0 · Reply

CautiousInvestor538 May. 13 at 11:21 PM

$ICLR short

0 · Reply

Armonica423 May. 10 at 10:08 PM

$ICLR Big exposure for CYDY at 3 oncology conferences this coming week, do your dd research

0 · Reply

JarvisFlow May. 2 at 9:30 PM

Barclays has updated their rating for Icon ( $ICLR ) to Equal-Weight with a price target of 155.

0 · Reply

JarvisFlow May. 2 at 4:55 PM

Goldman Sachs has updated their rating for Icon ( $ICLR ) to Neutral with a price target of 160.

0 · Reply

JarvisFlow May. 2 at 1:00 PM

Baird updates rating for Icon ( $ICLR ) to Neutral, target set at 192 → 160.

0 · Reply

briefingcom Apr. 29 at 12:14 PM

$ICLR: ICON (-1.2%) downgraded to Neutral from Overweight at JPMorgan; tgt $150 https://www.briefing.com/calendars/updown?Filter=downgrades&utm_campaign=updown&utm_medium=social&utm_source=x&utm_content=link

0 · Reply

anachartanalyst Apr. 29 at 11:01 AM

$ICLR https://anachart.com/wp-content/uploads/ana_temp/1745924483_soc-img.jpg

0 · Reply

JarvisFlow Apr. 29 at 11:00 AM

JP Morgan has adjusted their stance on Icon ( $ICLR ), setting the rating to Neutral with a target price of 265 → 150.

0 · Reply

Estimize Apr. 24 at 12:15 PM

Wall St is expecting 3.11 EPS for $ICLR Q1 [Reporting 04/30 AMC] http://www.estimize.com/intro/iclr?chart=historical&metric_name=eps&utm_co

0 · Reply

rocksteadystocks Apr. 23 at 2:11 AM

Several U.S. stocks have reached new 52-week lows. Here are some. $HRI $IRDM $APLS $MEDP $ICLR COME ROCK WITH US #daytrader #bitcoin #option #swingtrade #forex #invest #stocks #stockmarket #smallcap #optiontrading #investing #stockstrader #rocksteadystocks #comerockwithus #earningsseason #Earnings #52weekhigh #52weeklow #longs #shorts

0 · Reply

Estimize Apr. 16 at 12:09 PM

Wall St is expecting 3.12 EPS for $ICLR Q1 [Reporting 04/30 AMC] http://www.estimize.com/intro/iclr?chart=historical&metric_name=eps&utm_co

0 · Reply

JarvisFlow Apr. 14 at 5:21 PM

TD Cowen has adjusted their stance on Icon ( $ICLR ), setting the rating to Hold with a target price of 254 → 157.

0 · Reply

JarvisFlow Apr. 10 at 1:00 PM

Truist Securities updates rating for Icon ( $ICLR ) to Buy, target set at 262 → 208.

0 · Reply

Market Cap	11.83B
Revenue (ttm)	8.28B
Net Income (ttm)	791.47M
EPS (ttm)	N/A
PE Ratio	11.00
Forward PE	11.55
Profit Margin	9.56%
Debt to Equity Ratio	0.36

Volume	1,441,789
Avg Vol	1,635,566
Day's Range	N/A - N/A
Shares Out	80.76M
Stochastic %K	69%
Beta	1.15
Analysts	Strong Sell
Price Target	$183.75